• Most Popular
  • Most Shared
The Russian Soyuz space capsule lands with Expedition 20 Commander Gennady Padalka of Russia, Flight Engineer Michael Barratt of the U.S. and Canadian circus billionaire Guy Laliberte in the vast steppe near the town of Arkalyk in northern Kazakhstan October 11, 2009. REUTERS/Yuri Kochetkov/Pool

Pictures of the year: Science

A look at the year's best science photos.   Slideshow 

    New method generates stem cells safely from mice

    WASHINGTON
    Thu Oct 9, 2008 5:42pm EDT
    An undated image showing mouse embryonic stem cells stained with a flourescent green marker. REUTERS/National Science Foundation/Handout

    WASHINGTON (Reuters) - Japanese researchers who invented a way to make powerful stem cells out of ordinary cells say they have now found a safer way to do it.

    Science

    Shinya Yamanaka of Kyoto University in Japan and colleagues invented a new way to transform ordinary cells into embryonic-like stem cells called iPS cells, using a ring of genetic material called a plasmid.

    Working in mice, they generated induced pluripotent stem cells, or iPS cells, and said they believe the method can work in people, too, and is an important step toward a new field called regenerative medicine.

    Stem cells are the body's master cells, giving rise to all the tissues, organs and blood. Embryonic stem cells are considered the most powerful kinds of stem cells, as they have the potential to give rise to any type of tissue.

    But they are difficult to make, requiring the use of an embryo or cloning technology. Many people also object to their use, and several countries, including the United States, limit funding for such experiments.

    In the past year, several teams of scientists have reported finding a handful of genes that can transform ordinary skin cells into iPS cells, which look and act like embryonic stem cells.

    To get these genes into the cells, they have had to use retroviruses, which integrate their own genetic material into the cells they infect. This can be dangerous and can cause tumors and perhaps other effects.

    Last month U.S. researchers did the same thing using a harmless virus called an adenovirus, but the method was not efficient -- and introducing any virus into the body can pose risks.

    Yamanaka's team tried several different methods but eventually looped three of the genes needed into one plasmid and the fourth into another, and transplanted these into cells from a mouse embryo.

    The mouse embryonic cells reverted to a stem-like state and began behaving like embryonic stem cells.

    Yamanaka's team said the method was also not as efficient as using retroviruses but said they plan to try their method using human cells.

    If it works, some day doctors may be able to make tailor-made transplants to treat diseases in people by removing a few cells, transforming them in the lab and transplanting the new tissue or organs back in.

    (Reporting by Maggie Fox; Editing by Eric Beech)



    More from Reuters

    Photo

    U.S. health bill passes crucial Senate test

    WASHINGTON (Reuters) - A broad healthcare overhaul passed its first crucial test in the U.S. Senate on Monday, with 60 Democrats voting to put President Barack Obama's top legislative priority on a path to passage by Christmas. | Video

    A woman shops at a Sam's Club store, a division of Wal-Mart Stores, in Bentonville, Arkansas June 4, 2009. REUTERS/Jessica Rinaldi

    The food-stamp economy

    On the last day of every month, shoppers at Walmart load their carts with food and household items and wait for the midnight hour. Is this the new normal in America?  Full Article 

    Two men shake hands in a file photo.    REUTERS/File

    Let's make a deal

    The battered M&A sector will make a tepid recovery in the coming year and three hot sectors will lead the way, according to a Thomson Reuters analysis.  Full Article